Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDUA | P35475 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | STAT6 | P42226 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18819594 | 0.78 | IDUA (0.34) | IDUAMAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL18820165 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL23358401 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL21386691 | 0.76 | IDUA (0.34) | IDUA | |
| SCHEMBL18819590 | 0.74 | PYGB (0.39) | LMNA | |
| SCHEMBL12764243 | 0.74 | PYGB (0.39) | LMNA | |
| SCHEMBL18819584 | 0.72 | L3MBTL1 (0.33) | IDUA | |
| SCHEMBL22022186 | 0.71 | MANBA (0.40) | IDUAHIF1ALMNA | |
| SCHEMBL18463642 | 0.71 | MANBA (0.40) | IDUAHIF1ALMNA | |
| SCHEMBL373266 | 0.70 | IDUA (0.38) | IDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019104213-A1 | ANTIBIOFILM FORMULATIONS AND USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-05-31 | — | — | WO | claimed |
| WO-2019104213-A1 | ANTIBIOFILM FORMULATIONS AND USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-05-31 | — | — | WO | disclosed |
| US-9827277-B2 | Sulphated polysaccharide composition | Universite Blaise Pascal—Clermont II (FR) | 2017-11-28 | — | — | US | disclosed |
| US-20150328253-A1 | SULPHATED POLYSACCHARIDE COMPOSITION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2015-11-19 | — | — | US | disclosed |
| CN-104357364-A | Streptomycete strain and method for preparing alkali-resistant salt-resistant xylanase by using same | UNIV SHENYANG CHEMICAL TECH | 2015-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150328253-A1 | SULPHATED POLYSACCHARIDE COMPOSITION | ALG1, RPS7, RPS3A | IDUA 1409/4885MAPK1 3306/4885TP53 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.